Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

scientific article published on 29 April 2018

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41409-018-0189-2
P698PubMed publication ID29706650

P50authorMarta PalomoQ87057029
Maria Teresa CibeiraQ87885213
Laura RosiñolQ87885216
Joan BladéQ87885218
Alex BatallerQ88506849
Enric CarrerasQ90590294
Montserrat RoviraQ90625179
Francesc Fernández-AvilésQ90625182
María Suárez-LledóQ124079292
Gonzalo Gutiérrez-GarcíaQ58190510
Maribel Diaz-RicartQ59707025
Laura MagnanoQ62666471
P2093author name stringCarmen Martínez
Ana Moreno
Sofia Jorge
Carlos Fernández de Larrea
Alvaro Urbano-Ispizua
Luis Gerardo Rodríguez-Lobato
Marta Garrote
P2860cites workRegression modeling of competing risk using R: an in depth guide for cliniciansQ82452948
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantationQ82954860
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myelomaQ87012378
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTQ24685958
Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantationQ33944909
Engraftment syndrome following hematopoietic stem cell transplantationQ34298239
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical reviewQ34685502
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial.Q35598758
Survival analysis in hematologic malignancies: recommendations for cliniciansQ36036279
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management ApproachQ36264701
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndromeQ36575315
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatmentQ36983064
Optimal use of G-CSF administration after hematopoietic SCT.Q37442645
Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma.Q37559470
The role of the endothelium in the short-term complications of hematopoietic SCT.Q37860915
Engraftment syndrome: double-edged sword of hematopoietic cell transplantsQ38315390
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosisQ40306199
Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment SyndromeQ40347834
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infectionQ40517545
Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantationQ40541991
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteriaQ40563612
Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).Q40564199
Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosisQ40588563
Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndromeQ40615300
An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell doseQ40624714
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single centerQ43198285
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalizationQ43462115
At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative studyQ43920667
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms.Q48019681
Autologous stem cell transplantation in multiple myeloma is not dead but alive and well.Q48058540
Engraftment syndrome, the Emperor's new clothes and the artist formerly known as Prince.Q53628837
Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple MyelomaQ60218172
Recombinant human granulocyte-macrophage colony-stimulating factor produces feverQ69916369
Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administrationQ73446036
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancerQ74219120
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantationQ74492531
Competing risk analysis using R: an easy guide for cliniciansQ80466908
Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantationQ81018139
P433issue12
P304page(s)1541-1547
P577publication date2018-04-29
P1433published inBone Marrow TransplantationQ4941523
P1476titleInnovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
P478volume53

Reverse relations

cites work (P2860)
Q99730640Prophylactic corticosteroid use prevents engraftment syndrome in patients after autologous stem cell transplantation
Q94671653The induction strategies administered in the treatment of multiple myeloma exhibit a deleterious effect on the endothelium

Search more.